Fraunhofer Institute for Cell Therapy and Immunology IZI


Business field

Cell and gene therapy


Business field

Drugs and vaccines


Business field

Molecular diagnostics and immunodiagnostics


Business field

Extracorporeal therapies

We transfer biomedical research into the clinic.

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering. One of the institute‘s main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharma­ceuticals and medical engineering.

The Fraunhofer IZI develops, optimizes and validates methods, materials and products within the business fields cell and gene therapy, drugs and vaccines, molecular diagnostics and immunodiagnostics, as well as extracorporeal therapies. Its areas of competence lie in cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation. Research in these areas is centered around developments in immuno-oncology and infectious disease pathology. The S3 safety laboratory allows research and development activities to be conducted and highly pathogenic agents investigated under biosafety level 3 conditions.

The institute works in close cooperation with hospital institutions and performs quality tests besides manufacturing investigational medicinal products in line with GMP requirements. Furthermore, it supports partners in developing processes for the pharmaceutical production of ATMPs and biologicals, for example by helping them to obtain manufacturing licenses.


Latest press releases


Fraunhofer Institute for Cell Therapy and Immunology wins an award in the Mecklenburg-Vorpommern competition for ideas for the healthcare industry

On 2 May 2024, Reinhard Meyer, minister for economic affairs of Mecklenburg-Vorpommern, presented the awards to the winners of the “Innovative ideas for the healthcare sector” competition, in the state’s capital, Schwerin. The seven winners included a project proposal by Fraunhofer IZI’s Rostock Department of Extracorporeal Therapy. The successful project was “mi4ASSESS-MED – A marketing and innovation strategy to strengthen the market position and competitiveness of ASSESS-MED”.
more info


Biomarkers for the successful treatment of tumors in the bone marrow identified

CAR-T cell therapy has been established as an effective treatment for various haematological cancers. However, the treatment does not have the same level of success in all patients. In a current clinical study, researchers from the University of Leipzig Medical Center and the Fraunhofer Institute for Cell Therapy and Immunology IZI have identified various biomarkers which are linked to the response to CAR-T cell therapy in multiple myeloma, a type of bone marrow cancer. The results of their study were published in the renowned journal Nature Cancer.
more info


Fraunhofer IZI expands expertise in the field of cellular immunotherapy with new branch office in Würzburg

A new branch of the Fraunhofer IZI was established in Würzburg at the beginning of 2024. Under the direction of Prof. Dr. Michael Hudecek, new technologies for cellular immunotherapies for the treatment of various cancers are being developed and clinically tested.
more info


New approach to early cancer detection honored with Hugo Geiger Prize

In her doctoral thesis, Dr. Susann Allelein from the Fraunhofer Institute for Cell Therapy and Immunology IZI investigated a new approach for the early detection of prostate cancer in particular. She was awarded the 3rd Hugo Geiger Prize 2023 on February 28, 2024. The prize, awarded by the Free State of Bavaria and the Fraunhofer-Gesellschaft, recognizes outstanding, application-oriented doctoral theses.
more info

Press / media


As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.



The Fraunhofer IZI offers its partners and guests space for communication.

Utilize our modern and representative premises for your event. The generously proportioned and modern space offered at the Institute provides space for, e. g., workshops, symposia, conferences and lectures.



Fraunhofer Prize for “Human- and Environment-Centered Technology” 2021

For a vaccine production process that is faster, more efficient and more environmentally friendly.


Fraunhofer lighthouse project

Automated production technologies for mRNA-based drugs


Saxon future cluster



Annual report 2023/24

The annual report gives you an insight into the structure of the Fraunhofer IZI, our services, important events and publications, offers, as well as selected project examples.

Research projects funded by the EU

Research projects at Fraunhofer IZI that are supported by the Land of Saxony / Saxony-Anhalt / Mecklenburg-Western Pomerania using funds provided by the European Regional Development Fund (ERDF).


Research areas and core competencies

The Fraunhofer IZI offers R&D services for pharmaceutical, biotechnological and medical technology companies as well as for partners from research institutions, hospitals and diagnostic laboratories.

Jobs / career

We keep you informed on current job offers at the Fraunhofer IZI. Find out about the possibilities the Fraunhofer-Gesellschaft could offer you as an employer.


We gladly provide our clients and partners as well as the interested public with information on our research activities.



Fraunhofer IZI


Perlickstraße 1
04103 Leipzig

Phone +49 341 35536-1000
Fax +49 341 35536-8-1000


Social Media